Good Morning, Traders!…👋

U.S. stock futures edged higher Tuesday morning as investors welcomed easing geopolitical tensions and eyed upcoming comments from Federal Reserve Chair Jerome Powell. Futures tied to the Nasdaq jumped nearly 1%, driven by strength in tech stocks, notably Nvidia, while S&P 500 and Dow futures also posted solid gains, setting a positive tone for today's trading session.

Investor sentiment improved significantly following reports of a comprehensive ceasefire between Israel and Iran, calming recent market anxiety and sending crude oil prices sharply lower. Brent and WTI crude both dropped over 3%, easing concerns around energy inflation and giving stocks additional support.

Today, market focus shifts to Fed Chair Powell’s congressional testimony, where traders will seek insights into the central bank's policy direction. Meanwhile, corporate earnings from FedEx and Carnival will provide further cues on economic health. Investors are poised for a potentially eventful day, balancing cautious optimism with ongoing vigilance.

Earnings Watch

Earnings hit today from Carnival $CCL, TD SYNNEX $SNX, and TH International $THCH before open, plus FedEx $FDX, AeroVironment $AVAV, and BlackBerry $BB after close.

Analysts expect CCL to post $0.24 EPS with cruise demand, SNX to hit $2.70 EPS, THCH at -$0.05 EPS, FDX to deliver $5.85 EPS with logistics strength, AVAV at $0.78 EPS, and BB at -$0.02 EPS—could these beats spark rallies?

Happening Today

✓ 08:30 AM ET – Current Account (Q1)
✓ 09:00 AM ET – S&P/CS HPI Composite - 20 n.s.a. (MoM)(YoY) (Apr)
✓ 10:00 AM ET – CB Consumer Confidence (Jun)
✓ 12:00 PM ET – 2-Year Note Auction
✓ 04:30 PM ET – API Weekly Crude Oil Stock

PREMARKET SNAPSHOT 📈

U.S. equity futures are modestly higher this morning as markets rally on President Trump’s announcement of an Israel–Iran ceasefire, which triggered a sharp drop in oil prices (~3–4%), eased geopolitical risk, and bolstered hopes for a Fed rate cut later in the year.

SECTOR SNAPSHOT✨

Markets rebounded strongly across most sectors, with Consumer Discretionary (+1.75%), Real Estate (+1.49%), and Consumer Staples (+1.30%) leading the gains. Technology, Industrials, and Financials also posted solid advances. The only drag came from Energy (-2.51%), which declined sharply, while all other sectors ended in the green, reflecting broad-based optimism.

PreMarket Unusual Volume Stocks

📈 Currenc Group Inc. ($CURR) is up +8.25% with 170.62K shares traded, a 3,553% surge above its average. The spike hints at renewed trader interest, possibly driven by anticipation of news or momentum trading.

📈 iBio, Inc. ($IBIO) is rallying +74.06% on volume of 16.66M, which is 1,639% higher than usual. The biotech stock is drawing strong interest. Investors are likely reacting to industry news or company-specific catalysts.

📈 COMPASS Pathways Plc ($CMPS) gains +8.94% with 306.95K shares changing hands—1,600% above average. The move suggests traders are eyeing the psychedelic therapeutics sector amid increasing institutional focus.

📈 PLUS THERAPEUTICS, Inc. ($PSTV) jumps +13.89% with 38.24M shares traded, up 433% from average. A surge like this often signals investor enthusiasm around micro-cap biotech plays.

📈 Rezolve AI PLC ($RZLV) is advancing +11.76% with 1.13M shares moving early, a 377% increase. The AI theme remains red-hot, and this name appears to be catching a wave of attention.

Premarket Picks

iBio, Inc. (IBIO) is leading the surge with a pre-market price of $1.12, up 57.21%. This spike comes ahead of its June 24 conference call, where the company plans to reveal new advances in obesity and cardiometabolic treatments, along with announcing a third target in its collaboration with AstralBio.

Nektar Therapeutics (NKTR) is also seeing strong activity, with its pre-market price at $12.40, up nearly 30%. The boost follows news of a webcast scheduled for today at 8:15 am ET, where Nektar will present Phase 2b trial results for rezpegaldesleukin in atopic dermatitis.

Klotho Neurosciences, Inc. (KLTO) rose 11.66% to $1.34 pre-market. The company announced a partnership with researchers from the Okinawa Research Center for Longevity Science to explore why many Okinawa residents live long, healthy lives, often surpassing 100 years.

Korea Electric Power Corporation (KEP) saw a 20.08% increase to $12.44 pre-market following the company’s filing of a 6-K form with the SEC.

Below is a complete list of hot stocks in pre-market today:

Top Upgrades:

1. Capital Southwest Corporation (CSWC)

Analyst Firm: Citizens JMP
Upgraded: Market Perform to Outperform
Price Target: $25
Yesterday's Close: $21.23

Citizens JMP has raised its rating on Capital Southwest, moving it from "Market Perform" to "Outperform," and set a new price target of $25. Analysts have set a high price target of $25.00 for Capital Southwest, with a median of $23.00 and a low of $21.00. The average target price stands at $22.50. Capital Southwest is a publicly owned company that focuses on investing in growing businesses.

2. Electronic Arts Inc. (EA)

Analyst Firm: Roth Capital
Upgraded: Neutral to Buy
Price Target: $185
Yesterday's Close: $154.41

Roth Capital has boosted its rating on Electronic Arts from "Neutral" to "Buy," increasing its price target from $175 to $185. For Electronic Arts, the high price target is $210.00, with a median of $166.00 and a low of $148.00. The average price target is $170.70. EA is known for creating and selling games and content across consoles, PCs, and mobile devices.

3. MakeMyTrip Limited (MMYT)

Analyst Firm: Macquarie
Upgraded: Neutral to Outperform
Price Target: $110
Yesterday's Close: $91.51

Macquarie analyst Aditya Suresh upgraded MakeMyTrip (MMYT) from "Neutral" to "Outperform," assigning a new target price of $110. MakeMyTrip’s stock price target ranges from a low of $110.00 to a high of $135.00, with a median of $120.00 and an average of $122.11. The company offers travel bookings, tour packages, insurance, visa services, and currency exchange.

Maeve Grace
Editor In Chief
Premium Stock Alerts

Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.

Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.